A STUDY FROM THE CELLULAR ASPECT ON THE PATHOPHYSIOLOGY AND TREATMENT OF MULTIPLE ORGAN FAILURE
A STUDY FROM THE CELLULAR ASPECT ON THE PATHOPHYSIOLOGY AND TREATMENT OF MULTIPLE ORGAN FAILURE
批准号:
02454351
负责人:
HIRASAWA Hiroyuki
金额:
$4.29万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1992
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have claimed that multiple organ failure (MOF) is the summation of the cellular injury in vital organs. Therefore therapeutic approaches to the MOF should be considered through the improvement of cellular dysfunction in the vital organs. For such approach the parameters which can express the severity of cellular injury is essential. The cellular injury score (CIS), which is derived from three different cellular metabolic sequences, arterial ketone body ratio (AKBR), serum osmolality gap and blood lactate and is proposed by us is found to be a good index to evaluate the severity of the patients with MOF. The impairment of cellular function following various insults such as sepsis, trauma, and shock can be caused through two mechanism: derangement in tissue oxygen metabolism and humoral mediators. Therefore for the treatment and/or prevention of cellular injury in the critically ill should be achieved through the improvement of tissue oxygen metabolism and the counter-measures for the humoral mediators. We have found that continuous hemofiltration (CHF)/continuous hemodiafiltration(CHDF) effectively remove the various humoral mediators and that those continuous blood purifications are also effective in the improvement of tissue oxygen metabolism following the administration of catecholamines. These results suggest that improvement of cellular dysfunction is an effective treatment/prophylaxis for MOF.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
志賀 英敏: "MOF患者の全身状態評価法としてのAPACHE II、CISおよびAPACHE Hの比較" 外科と代謝・栄養. 27. 21-28 (1992)
Hidetoshi Shiga:“APACHE II、CIS 和 APACHE H 作为评估 MOF 患者一般状况的方法的比较”《外科、代谢和营养》27. 21-28 (1992)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
平澤 博之: "MOF治療 -最近の動向-" 綜合臨牀. 40. 2629-2636 (1991)
Hiroyuki Hirasawa:“MOF 治疗 - 最新趋势 -” Sogo Rinpo。40. 2629-2636 (1991)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
平澤 博之: "細胞レベルからみた細胞障害とその対策 分担執筆 「臓器障害と細胞代謝」" メジカルビュ-社, 10 (1990)
Hiroyuki Hirasawa:“细胞损伤及其从细胞水平的对策。撰稿人:“器官损伤和细胞代谢”,Medical View-sha,10(1990)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
志賀 英敏: "MOF患者の全身状態評価法としてのAPACHEII、CISおよびAPACHE Hの比較" 外科と代謝・栄養. 27. 21-28 (1992)
Hidetoshi Shiga:“APACHE II、CIS 和 APACHE H 作为评估 MOF 患者一般状况的方法的比较”《外科、代谢和营养》27. 21-28 (1992)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
平澤 博之: "敗血症性多臓器不全" 循環制御. 11. 197-202 (1990)
Hiroyuki Hirasawa:“脓毒性多器官衰竭”循环控制。11. 197-202 (1990)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 22 条
TAILOR-MADE MEDICINE AGAINST PATHOPHYSIOLOGICAL RESPONSE TO STRESS BASED ON THE GENOME ANALYSIS
-
批准号:14370348
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.63万
-
财政年份:2002
-
负责人:HIRASAWA Hiroyuki
-
依托单位:
Cytokine modulation with continuous hemodiafiltration for treatment and prevention of multiple organ failure
-
批准号:11470238
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.96万
-
财政年份:1999
-
负责人:HIRASAWA Hiroyuki
-
依托单位:
ENHANCEMENT OF RETICULOENDOTHELIAL FUNCTION IN THE TREATMENT OF ACUTE HEPATIC FAILURE
-
批准号:61570734
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1986
-
负责人:HIRASAWA Hiroyuki
-
依托单位:
海外基金